Mutations in Isocitrate Dehydrogenase 1 and 2 Occur Frequently in Intrahepatic Cholangiocarcinomas and Share Hypermethylation Targets with Glioblastomas

Abstract

Mutations in the genes encoding isocitrate dehydrogenase, IDH1 and IDH2, have been reported in gliomas, myeloid leukemias, chondrosarcomas and thyroid cancer. We discovered IDH1 and IDH2 mutations in 34 of 326 (10%) intrahepatic cholangiocarcinomas. Tumor with mutations in IDH1 or IDH2 had lower 5-hydroxymethylcytosine and higher 5-methylcytosine levels, as well as increased dimethylation of histone H3 lysine 79 (H3K79). Mutations in IDH1 or IDH2 were associated with longer overall survival (P=0.028) and were independently associated with a longer time to tumor recurrence after intrahepatic cholangiocarcinoma resection in multivariate analysis (P=0.021). IDH1 and IDH2 mutations were significantly associated with increased levels of p53 in intrahepatic cholangiocarcinomas, but no mutations in the p53 gene were found, suggesting that mutations in IDH1 and IDH2 may cause a stress that leads to p53 activation. We identified 2309 genes that were significantly hypermethylated in 19 cholangiocarcinomas with mutations in IDH1 or IDH2, compared with cholangiocarcinomas without these mutations. Hypermethylated CpG sites were significantly enriched in CpG shores and upstream of transcription start sites, suggesting a global regulation of transcriptional potential. Half of the hypermethylated genes overlapped with DNA hypermethylation in IDH1-mutant gliobastomas, suggesting the existence of a common set of genes whose expression may be affected by mutations in IDH1 or IDH2 in different types of tumors.

DOI: 10.1038/onc.2012.315

Extracted Key Phrases

7 Figures and Tables

020040020132014201520162017
Citations per Year

1,244 Citations

Semantic Scholar estimates that this publication has 1,244 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Wang2013MutationsII, title={Mutations in Isocitrate Dehydrogenase 1 and 2 Occur Frequently in Intrahepatic Cholangiocarcinomas and Share Hypermethylation Targets with Glioblastomas}, author={Pu Wang and Qiong-zhu Dong and Chong Zhang and Pei-fen Kuan and Yufeng Liu and William R. Jeck and Jesper B\oje Andersen and Wenqing Jiang and Gleb L. Savich and Ting-Xu Tan and James Todd Auman and Janelle M. Hoskins and Anne D. Misher and Catherine D. Moser and Scott M. Yourstone and Jin Woo Kim and Kristian Cibulskis and Gad Getz and Heike V. Hunt and Snorri Thorgeirsson and Paul I Heidekrueger and Dan Ye and Kun-Liang Guan and Yue Xiong and Lun-xiu Qin and Derek Y. Chiang}, booktitle={Oncogene}, year={2013} }